The world’s most advanced artificial heart, including a pipeline of transformative, next-generation cardiac technologies, are set to be developed and commercialised by a Monash University-led consortium.
What began as a heart research project looking at ways to understand a potentially fatal but preventable disease has evolved from the biomedical into one more in keeping with an Indigenous perspective.
Cardio-oncology services will provide much-needed access to heart healthcare for people with, or who have survived, cancer, and focus on the prevention of heart disease.
The $543 million Victorian Heart Hospital will be Australia's first dedicated facility to tackle the country's No.1 killer.
Dummy text
